Opyl Limited announced an update to shareholders on the successful completion of a key milestone in the development of the clinical trial recruitment platform. The platform is continuing its development pathway and on track for market launch on 20 May 2021. The next milestones in the development pathway includes a series of focus groups and onboarding a number of clients prepared to trial the platform. The first of a series of five customer and patient focus groups commenced on 8 April 2021 and will continue through until the end of May. Feedback from early clients and from focus group discussions is critical in the ongoing refining of the features and experience on the platform as well as confirming and contributing to the global marketing and sales strategy. The official launch on 20 May 2021 will be at the International Clinical Trials Day. Michelle Gallaher will be a speaker at a number of events that week, most notably at AusMedtech 2021, introducing the technology by presenting on personalisation of clinical trials and how new technologies are influencing clinical trial design and delivery.